Evidence map›Paper›PMID 32292904›Full record

ArticleKidney medicine

COVID-19 Pneumonia in a Hemodialysis Patient.

Bin Tang, Sijia Li, Yuwan Xiong, Ming Tian, Jianbin Yu, Lixia Xu, Li Zhang, Zhuo Li, Jianchao Ma, Feng Wen and 4 more

Abstract readCase Reports
In one paragraph

Article in Kidney medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Current status of COVID-19 among hemodialysis patients in the East Azerbaijan Province of Iran.Hemodialysis international. International Symposium on Home Hemodialysis · 2021
    Article
  11. Kidney involvement in coronavirus-associated diseases (Review).Experimental and therapeutic medicine · 2021
    Review
  12. Canadian family physician Medecin de famille canadien · 2021
    Review
  13. Medication use during COVID-19: Review of recent evidence.Canadian family physician Medecin de famille canadien · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. COVID-19 in hemodialysis patients in Colombia: Report of seven casesBiomedica : revista del Instituto Nacional de Salud · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bin TangDepartment of Nephrology, Blood Purifiction Center, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Sijia LiDepartment of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Yuwan XiongDepartment of Nephrology, Blood Purifiction Center, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Ming TianDepartment of Nephrology, Blood Purifiction Center, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Jianbin YuDepartment of Nephrology, Blood Purifiction Center, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Lixia XuDepartment of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Li ZhangDepartment of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Zhuo LiDepartment of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Jianchao MaDepartment of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Feng WenDepartment of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Zhonglin FengDepartment of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Xinling LiangDepartment of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Wei ShiDepartment of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Shuangxin LiuDepartment of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is a highly infective disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). Previous studies of the COVID-19 pneumonia outbreak were based on information from the general population. Limited data are available for hemodialysis patients with COVID-19 pneumonia. This report describes the clinical characteristics of COVID-19 in an in-center hemodialysis patient, as well as our experience in implementing steps to prevent the spread of COVID-19 pneumonia among in-center hemodialysis patients. The diagnosis, infection control, and treatment of COVID-19 in hemodialysis patients are discussed in this report, and we conclude with recommendations for how a dialysis facility can respond to COVID-19 based on our experiences.

Indexed as

Coronavirus disease 2019 (COVID-19)epidemichemodialysislopinavir/ritonavirsevere acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2)

Identifiers

PMID32292904
PMCPMC7103984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.